Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Mathieu Uhart"'
Autor:
Amy Lee, Benjamin Davido, Ekkehard Beck, Clarisse Demont, Keya Joshi, Michele Kohli, Michael Maschio, Mathieu Uhart, Nadia El Mouaddin
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
An evaluation was conducted to predict the economic and clinical burden of vaccinating all immunocompromised (IC) individuals aged ≥30 years with mRNA-1273 variant-adapted COVID-19 vaccines versus BNT162b2 variant-adapted vaccines in Fall 2023 and
Externí odkaz:
https://doaj.org/article/5ba6dcdd0a774b0eb36b302ad63407a5
Autor:
Philip O. Buck, Dumingu Aparna Gomes, Ekkehard Beck, Noam Kirson, Matthew Mattera, Stuart Carroll, Bernhard Ultsch, Kavisha Jayasundara, Mathieu Uhart, Louis P. Garrison, Jr.
Publikováno v:
Vaccines, Vol 12, Iss 3, p 234 (2024)
The COVID-19 pandemic’s dramatic impact has been a vivid reminder that vaccines—especially in the context of infectious respiratory viruses—provide enormous societal value, well beyond the healthcare system perspective which anchors most Health
Externí odkaz:
https://doaj.org/article/7952172987994499adfb351a5b30b4ed
Autor:
Yann de Rycke, Florence Tubach, Alexandre Lafourcade, Sylvie Guillo, Marie Dalichampt, André Dahlab, Xavier Bresse, Mathieu Uhart, Christine Bergeron, Hélène Borne, Charlotte Cancalon, Audrey Lajoinie, Stève Bénard
Publikováno v:
PLoS ONE, Vol 15, Iss 2, p e0228660 (2020)
Until 2018, cervical cancer screening in France was an unorganized individual screening, with the exception of some pilot programs in some territories. We aimed to assess, before the implementation of organized cervical cancer screening and human pap
Externí odkaz:
https://doaj.org/article/3cf5312671314f619fc1dfd4fd1b4e8d
Autor:
Francesco Saverio Mennini, Paolo Bonanni, Florence Bianic, Chiara de Waure, Gianluca Baio, Giacomo Plazzotta, Mathieu Uhart, Alessandro Rinaldi, Nathalie Largeron
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 15, Iss 1, Pp 1-14 (2017)
Abstract Background In Italy HPV vaccination with the quadrivalent vaccine (Gardasil®) is offered actively and free of charge to girls aged 12 since 2007. A nine-valent vaccine (Gardasil 9®) received the European market authorization in 2015 to pro
Externí odkaz:
https://doaj.org/article/a1cee773c6eb4b94ae65c032171d864c
Publikováno v:
Papillomavirus Research, Vol 3, Iss , Pp 73-79 (2017)
Introduction: Since 2007, HPV vaccination programs have been implemented in Europe. Significant real-life impact has already been reported in countries where the programs have been successfully implemented. In France, HPV vaccination coverage rate (V
Externí odkaz:
https://doaj.org/article/cf8128bcd04448b5a7ec3642e759a003
Autor:
Laurent Abramowitz, Jean Lacau Saint Guily, Micheline Moyal-Barracco, Christine Bergeron, Hélène Borne, André Dahlab, Xavier Bresse, Mathieu Uhart, Charlotte Cancalon, Laura Catella, Stève Bénard
Publikováno v:
PLoS ONE, Vol 13, Iss 9, p e0202564 (2018)
Human papillomaviruses (HPV) infection is now known to be responsible for almost all cervical cancers, and for a substantial fraction of Head and Neck cancers (HNCs). However, comprehensive epidemiological and economic data is lacking in France, espe
Externí odkaz:
https://doaj.org/article/6651776a0f854d97afa0186875a6cf7a
Autor:
Magali Lemaitre, Fouad Fayssoil, Fabrice Carrat, Pascal Crepey, Jacques Gaillat, Gaetan Gavazzi, O. Launay, Anne Mosnier, Marie-Cecile Levant, Mathieu Uhart
Publikováno v:
Influenza and Other Respiratory Viruses
Influenza and Other Respiratory Viruses, 2022, 16 (4), pp.717-725. ⟨10.1111/irv.12962⟩
Influenza and Other Respiratory Viruses, 2022, 16 (4), pp.717-725. ⟨10.1111/irv.12962⟩
International audience; BackgroundIn France, each year, influenza viruses are responsible for seasonal epidemics leading to 2–6 million cases. Influenza can cause severe disease that may lead to hospitalization or death. As severe disease may be du
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaf88718635982fefd64f0fb5f404884
https://pubmed.ncbi.nlm.nih.gov/35014194
https://pubmed.ncbi.nlm.nih.gov/35014194
Autor:
Laurent, Bourguignon, Michel, Ducher, David, Matanza, Nathalie, Bleyzac, Mathieu, Uhart, Emmanuel, Odouard, Pascal, Maire, Sylvain, Goutelle
Publikováno v:
Fundamentalclinical pharmacology. 26(2)
Population pharmacokinetics and simulation techniques currently play an important role in new drug development. This paper illustrates the potential value of those methods in postmarketing safety assessment, using buflomedil in elderly patients as an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bd6ddb8ff6019c79aff401a913a4a8d5
https://pubmed.ncbi.nlm.nih.gov/22004557
https://pubmed.ncbi.nlm.nih.gov/22004557